Pages that link to "Q43246075"
Jump to navigation
Jump to search
The following pages link to Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation (Q43246075):
Displaying 50 items.
- Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide (Q21195191) (← links)
- Prolactin-induced protein mediates cell invasion and regulates integrin signaling in estrogen receptor-negative breast cancer (Q21195199) (← links)
- Targeting androgen receptor in estrogen receptor-negative breast cancer (Q24312457) (← links)
- The first decade of estrogen receptor cistromics in breast cancer (Q26767112) (← links)
- Steroid hormones, steroid receptors, and breast cancer stem cells (Q26799113) (← links)
- Androgen receptor, EGFR, and BRCA1 as biomarkers in triple-negative breast cancer: a meta-analysis (Q26823419) (← links)
- Arylamine N-acetyltransferase 1: a novel drug target in cancer development (Q26829025) (← links)
- Targeting the androgen receptor in prostate and breast cancer: several new agents in development (Q27009424) (← links)
- Concepts and targets in triple-negative breast cancer: recent results and clinical implications (Q28078992) (← links)
- Estrogen-Related Receptors in Breast Cancer and Prostate Cancer (Q28084030) (← links)
- A Brief Overview of the WHO Classification of Breast Tumors, 4th Edition, Focusing on Issues and Updates from the 3rd Edition (Q28305715) (← links)
- A Protective Role for Androgen Receptor in Clear Cell Renal Cell Carcinoma Based on Mining TCGA Data (Q31040253) (← links)
- Targeting oncogenic vulnerabilities in triple negative breast cancer: biological bases and ongoing clinical studies (Q33591876) (← links)
- A rare presentation of triple-negative apocrine breast carcinoma with metastases (Q33612920) (← links)
- Androgen Receptor as a Potential Target for Treatment of Breast Cancer (Q33625672) (← links)
- Estrogen and androgen-converting enzymes 17β-hydroxysteroid dehydrogenase and their involvement in cancer: with a special focus on 17β-hydroxysteroid dehydrogenase type 1, 2, and breast cancer (Q33728381) (← links)
- Molecular apocrine breast cancers are aggressive estrogen receptor negative tumors overexpressing either HER2 or GCDFP15. (Q33739841) (← links)
- Identification and use of biomarkers in treatment strategies for triple-negative breast cancer subtypes (Q33874621) (← links)
- Novel therapeutic strategies in the treatment of triple-negative breast cancer (Q33887682) (← links)
- Serum/glucocorticoid-regulated kinase 1 expression in primary human prostate cancers (Q33896203) (← links)
- Prevalence and predictors of androgen receptor and programmed death-ligand 1 in BRCA1-associated and sporadic triple-negative breast cancer (Q33915040) (← links)
- Androgen receptor (AR) expression in 400 breast carcinomas: is routine AR assessment justified? (Q33932665) (← links)
- Selective androgen receptor modulators (SARMs) negatively regulate triple-negative breast cancer growth and epithelial:mesenchymal stem cell signaling (Q33966915) (← links)
- Expression of the Androgen Receptor, pAkt, and pPTEN in Breast Cancer and Their Potential in Prognostication. (Q34092016) (← links)
- Molecular insights on basal-like breast cancer (Q34123314) (← links)
- Treatment options for patients with triple-negative breast cancer (Q34331406) (← links)
- Histone demethylase GASC1--a potential prognostic and predictive marker in invasive breast cancer (Q34475807) (← links)
- FABP7 and HMGCS2 are novel protein markers for apocrine differentiation categorizing apocrine carcinoma of the breast. (Q34497523) (← links)
- Male breast carcinoma: a clinicopathological and immunohistochemical characterization study. (Q34501947) (← links)
- Androgen receptors and serum testosterone levels identify different subsets of postmenopausal breast cancers. (Q34512957) (← links)
- A Tale of Two Signals: AR and WNT in Development and Tumorigenesis of Prostate and Mammary Gland. (Q34550256) (← links)
- A Feedback Loop between Androgen Receptor and ERK Signaling in Estrogen Receptor-Negative Breast Cancer (Q34551559) (← links)
- Coagulation factor VII is regulated by androgen receptor in breast cancer (Q34995790) (← links)
- Dietary lignan intake and androgen receptor expression in breast tumors (Q34995845) (← links)
- Triple-negative breast cancer: new perspectives for targeted therapies. (Q35001758) (← links)
- Androgen receptor expression in breast cancer in relation to molecular phenotype: results from the Nurses' Health Study (Q35083868) (← links)
- Androgen receptor status is a prognostic marker in non-basal triple negative breast cancers and determines novel therapeutic options (Q35088745) (← links)
- A case of long term survival with skeletal only metastatic breast cancer (Q35100559) (← links)
- Management Options in Triple-Negative Breast Cancer (Q35155460) (← links)
- In silico discovery and validation of potent small-molecule inhibitors targeting the activation function 2 site of human oestrogen receptor α (Q35180278) (← links)
- Synergy between inhibitors of androgen receptor and MEK has therapeutic implications in estrogen receptor-negative breast cancer (Q35558993) (← links)
- Expression of the androgen receptor and its correlation with molecular subtypes in 980 chinese breast cancer patients (Q35668330) (← links)
- Androgen receptor expression is usually maintained in initial surgically resected breast cancer metastases but is often lost in end-stage metastases found at autopsy. (Q35894728) (← links)
- Cross-regulation between FOXA1 and ErbB2 signaling in estrogen receptor-negative breast cancer (Q38639760) (← links)
- HER2 status in molecular apocrine breast cancer: associations with clinical, pathological, and molecular features. (Q36014239) (← links)
- Triple-negative breast cancer: are we making headway at least? (Q36061177) (← links)
- Minireview: The androgen receptor in breast tissues: growth inhibitor, tumor suppressor, oncogene? (Q36113793) (← links)
- Androgen receptor as a targeted therapy for breast cancer. (Q36135807) (← links)
- The Role of Androgen Receptor in Breast Cancer. (Q36275556) (← links)
- Synergistic control of sex hormones by 17β-HSD type 7: a novel target for estrogen-dependent breast cancer (Q36331426) (← links)